Apriem Advisors Biogen Inc. Transaction History

Apriem Advisors

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$187.54 - $223.02 $76,516 - $90,992	-408 Reduced 19.36%	1,699 $346,000
Q1 2022 May 10, 2022	SELL	$193.77 - $244.14 $159,278 - $200,683	-822 Reduced 28.06%	2,107 $444,000
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $7,389 - $9,496	-33 Reduced 1.11%	2,929 $703,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $6.17 Million - $8.04 Million	-21,791 Reduced 88.03%	2,962 $838,000
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $9.43 Million - $15.1 Million	-36,409 Reduced 59.53%	24,753 $8.57 Million
Q1 2021 May 10, 2021	BUY	$242.95 - $284.63 $1.99 Million - $2.33 Million	8,172 Added 15.42%	61,162 $17.1 Million
Q4 2020 Feb 04, 2021	SELL	$236.26 - $355.63 $778,949 - $1.17 Million	-3,297 Reduced 5.86%	52,990 $13 Million
Q3 2020 Nov 10, 2020	BUY	$264.77 - $305.71 $209,433 - $241,816	791 Added 1.43%	56,287 $16 Million
Q2 2020 Aug 07, 2020	BUY	$258.66 - $342.55 $588,192 - $778,958	2,274 Added 4.27%	55,496 $14.8 Million
Q1 2020 May 07, 2020	BUY	$268.85 - $341.04 $28,498 - $36,150	106 Added 0.2%	53,222 $16.8 Million
Q4 2019 Feb 10, 2020	BUY	$220.06 - $304.07 $711,453 - $983,058	3,233 Added 6.48%	53,116 $15.8 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $10.3 Million - $11.6 Million	47,363 Added 1879.48%	49,883 $11.6 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $552,610 - $609,134	2,520 New	2,520 $589,000
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $12,327 - $16,120	-42 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $10,815 - $12,890	42 New	42 $12,000

1,007

131M

1.77M

2.34M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Apriem Advisors, based on Form 13F filings with the SEC.

Stay updated on Apriem Advisors with notifications on news.